Related Experiment Videos
Peripheral blood stem cell autografting: a new therapeutic option for AML?
British Journal of Haematology
|July 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Relapsed multiple myeloma: who benefits from salvage autografts?
Internal medicine journal·2012
How we mobilize haemopoietic stem cells.
Internal medicine journal·2011
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
British journal of haematology·2026
Autoimmune neutropenia in children: Test cells versus beads and a role for pro-LL-37 and absolute neutrophil count.
British journal of haematology·2026
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.
British journal of haematology·2026
Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).
British journal of haematology·2026
Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid-derived suppressor cells by myeloma cells.
British journal of haematology·2026
In a nutshell: Haematological immune-related adverse events.
British journal of haematology·2026
Real‑world implementation of rTMS for depression: a comparative study of Sweden and Japan.
Nordic journal of psychiatry·2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
American journal of hematology·2026
Rapid versus conventional glucocorticoid tapering in pure membranous LN: a multicentre retrospective study.
Rheumatology advances in practice·2026